Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Post-approval studies (Phase 4)Study completedNCT02032576
What this trial is testing

Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients

Who this might be right for
Major Depressive Episode
Kaohsiung Kai-Suan Psychiatric Hospital 170
Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Testing effectiveness (Phase 2)UnknownNCT02134262
What this trial is testing

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Who this might be right for
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Jichi Medical University 18
Early research (Phase 1)Looking for participantsNCT07025564
What this trial is testing

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06757387
What this trial is testing

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Peking University Cancer Hospital & Institute 45
Not applicableUnknownNCT06019221
What this trial is testing

Pediatric Relapsing Polychondritis : Diagnosis and Management in a French Retrospective Study

Who this might be right for
Relapsing Polychondritis
University Hospital, Strasbourg, France 20
Testing effectiveness (Phase 2)Study completedNCT03770416
What this trial is testing

Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma

Who this might be right for
Central Nervous System B-Cell Non-Hodgkin LymphomaRecurrent Central Nervous System LymphomaRefractory Central Nervous System Lymphoma
M.D. Anderson Cancer Center 18
Large-scale testing (Phase 3)Looking for participantsNCT04794777
What this trial is testing

Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

Who this might be right for
Prostate Cancer
Stefan Carlsson 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Study completedNCT01949519
What this trial is testing

Docetaxel and Lycopene in Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Medical University of South Carolina 24
Testing effectiveness (Phase 2)Study completedNCT03548207
What this trial is testing

JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264
What this trial is testing

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 218
Testing effectiveness (Phase 2)Study completedNCT00831597
What this trial is testing

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pharmatech 61
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT01646762
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Mayo Clinic 13
Large-scale testing (Phase 3)Study completedNCT03232073
What this trial is testing

Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Actelion 877
Not applicableStudy completedNCT06251986
What this trial is testing

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 310
Early research (Phase 1)Ended earlyNCT03761069
What this trial is testing

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcuteAML
PTC Therapeutics 33
Next Page